FDA 483 - Sooil Development Co., Ltd. - January 23, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Soci. Development Co., Ltd. in Gyeonggi-do, Gyeonggi, Korea, identified eight observations related to inadequate procedures across various quality system elements. The firm failed to establish adequate procedures for management review, quality audits, corrective and preventive actions, MDRs, calibration, environmental controls, supplier management, and training. These findings indicate significant deficiencies in the firm's quality management system.
ID · 53948ae5-cc26-4d71-ad4d-a5780da5abd1